TOUR:NASDAQTuniu Corporation Analysis
Data as of 2026-05-31 - not real-time
$5.91
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Tuniu trades at $5.91, well under its 20‑day ($6.15), 50‑day ($6.74) and 200‑day ($7.46) moving averages, signaling a bearish technical backdrop. The RSI of ~39 hints at near‑oversold conditions, while the MACD line sits just above its signal, offering a modest bullish nuance. Support sits at $5.71 and resistance at $7.79, with volume trending down and 30‑day volatility soaring above 68%, underscoring a choppy price environment.
Fundamentally, the company posts 20% revenue growth and a solid 58% gross margin, yet operating cash flow is deeply negative and the payout ratio hovers near 97%, making the eye‑popping 20% dividend yield unsustainable. Debt‑to‑equity exceeds 10, cash balances are high but offset by a $78M free‑cash‑flow deficit, and the forward PE of ~12 suggests cheap earnings but the underlying cash strain tempers optimism. Recent news of regaining Nasdaq’s minimum bid‑price compliance removes an immediate listing threat, but the broader Chinese travel sector remains cyclically and regulatorily exposed.
Fundamentally, the company posts 20% revenue growth and a solid 58% gross margin, yet operating cash flow is deeply negative and the payout ratio hovers near 97%, making the eye‑popping 20% dividend yield unsustainable. Debt‑to‑equity exceeds 10, cash balances are high but offset by a $78M free‑cash‑flow deficit, and the forward PE of ~12 suggests cheap earnings but the underlying cash strain tempers optimism. Recent news of regaining Nasdaq’s minimum bid‑price compliance removes an immediate listing threat, but the broader Chinese travel sector remains cyclically and regulatorily exposed.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Price below key moving averages and near support
- Decreasing volume and high short‑term volatility
- Negative operating cash flow and unsustainable dividend
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- 20% revenue growth and strong gross margin
- Regained Nasdaq compliance removing immediate delisting risk
- Continued cash‑flow deficit and high debt‑to‑equity ratio
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Persistent negative free cash flow and high leverage
- Cyclical Chinese travel demand and regulatory uncertainty
- Dividend yield driven by payout ratio near 100%, unlikely to persist
Key Metrics & Analysis
Financial Health
Revenue Growth20.30%
Profit Margin5.39%
P/E Ratio14.8
ROE3.02%
ROA1.00%
Debt/Equity10.90
P/B Ratio4.4
Op. Cash Flow$-109068000
Free Cash Flow$-78217504
Technical Analysis
TrendBearish
RSI39.5
Support$5.71
Resistance$7.79
MA 20$6.15
MA 50$6.74
MA 200$7.46
MACDBullish
VolumeDecreasing
Fear & Greed Index94.07
Valuation
Target Price$17.25
Upside/Downside191.96%
GradeUndervalued
TypeBlend
Dividend Yield20.25%
Risk Assessment
Beta0.90
Volatility68.32%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.